rethinkPeptides Search
Menu
Study breakdown

Probiotic PS128 Reduces Gut Pain Sensitivity by Normalizing Substance P and CGRP in the Gut-Brain Axis

AnimalModerate evidence
The takeaway

Lactobacillus plantarum PS128 reversed visceral hypersensitivity in IBS-like rats by normalizing substance P, CGRP, BDNF, and NGF levels across the gut-brain axis.

14 days reversed VH

Two weeks of daily PS128 probiotic completely reversed serotonin-induced visceral hypersensitivity

What the researchers found

PS128 reversed 5-HTP-induced visceral hypersensitivity and normalized substance P, CGRP, BDNF, and NGF distribution between dorsal root ganglia and spinal cord.

Why it matters

IBS affects 10-15% of people globally with limited treatment options. A probiotic that modulates the gut-brain axis through neuropeptide pathways offers a mechanistically grounded approach.

The numbers in context

10^9 CFU/day x 14 days; reversed SP, CGRP, BDNF, NGF changes; lowered corticosterone

How the study worked

Rat IBS model (5-HTP-induced visceral hypersensitivity without inflammation); 14 days oral PS128 (10⁹ CFU/day); colorectal distension with EMG; neuropeptide and neurotrophin levels in DRG, spinal cord; serum corticosterone; amygdala receptor expression.

Who was studied

Male Sprague-Dawley rats with 5-HTP-induced visceral hypersensitivity (IBS model)

What this study cannot tell us

Rat model — IBS in humans is more complex; 5-HTP model mimics only one aspect of IBS; 14 days may not reflect long-term effects; single probiotic strain tested.

How to read the evidence

Moderate — well-designed animal study with comprehensive neuropeptide analysis, but rat IBS model may not fully represent human disease.

When this study was published

Published in 2020; PS128 has been studied in clinical trials for other conditions since.

The bigger picture

The gut-brain axis is central to IBS pathology. This study provides molecular evidence for how a specific probiotic strain modulates pain neuropeptides, moving beyond "probiotics are good for gut health" to mechanistic understanding.

Questions still open

  • Would PS128 reduce visceral pain in human IBS clinical trials?
  • Is the neuropeptide normalization a direct effect of PS128 or mediated through gut microbiome changes?
  • Could PS128 be combined with other IBS treatments for enhanced benefit?

Common questions

How can a probiotic reduce pain?
PS128 normalized the levels of pain-signaling molecules (substance P, CGRP) in the nerve pathways connecting the gut to the brain, essentially recalibrating the pain sensitivity system.
Would this probiotic help my IBS?
The rat data is promising and the strain is commercially available, but human IBS clinical trials with PS128 would be needed to confirm these effects in people.

Read the original research

Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut-Brain Axis.

Probiotics and antimicrobial proteins, 12(3), 980-993

Citation

Liu, Yen-Wenn; Wang, Yen-Po; Yen, Hsu-Fang; Liu, Pei-Yi; Tzeng, Wen-Jian; Tsai, Chia-Fen; Lin, Han-Chieh; Lee, Fa-Yauh; Jeng, One-Jang; Lu, Ching-Liang; Tsai, Ying-Chieh. (2020). Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut-Brain Axis.. Probiotics and antimicrobial proteins, 12(3), 980-993. https://doi.org/10.1007/s12602-019-09595-w